Source:http://linkedlifedata.com/resource/pubmed/id/21587764
Switch to
Predicate | Object |
---|---|
rdf:type | |
pubmed:issue |
Pt 7
|
pubmed:dateCreated |
2011-5-18
|
pubmed:abstractText |
The title compound, [ReO(2)(C(6)H(7)N)(4)]PF(6), contains octa-hedral [ReO(2)(4-Mepy)(4)](+) cations (4-Mepy is 4-methyl-pyridine) and PF(6) (-) anions. Both the cation and the anion reside on special positions, the Re atom on a crystallographic center of inversion and the P atom on a C(2) axis parallel to the b axis. The Re(V) atom in the cation exhibits an octa-hedral coordination geometry with two O atoms in the apical positions and four N atoms of the 4-Mepy ligands in the equatorial plane. The Re=O and Re-N bond lengths fall in the typical ranges of trans-dioxidorhenium(V) complexes.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:status |
PubMed-not-MEDLINE
|
pubmed:issn |
1600-5368
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
66
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
m857-8
|
pubmed:dateRevised |
2011-11-11
|
pubmed:year |
2010
|
pubmed:articleTitle |
trans-Tetra-kis(4-methyl-pyridine-?N)dioxidorhenium(V) hexa-fluorido-phosphate.
|
pubmed:affiliation |
Research Laboratory for Nuclear Reactors, Tokyo Institute of Technology, 2-12-1-N1-34 Ookayama, Meguro-ku, Tokyo 152-8550, Japan.
|
pubmed:publicationType |
Journal Article
|